The Norovirus Diagnostics Market is expected to grow at a decent In Upcoming Years. The cutting-edge technologies, software, and automation are being efficiently driven by digital transformation. Everything – flexible hours of productivity and the evolution of new business is seeing the light of the day due to digital solutions being provided. Both – process and discrete industries would be able to lay their hands on the specific requirements of the end-users with digitization by their side. This would be the running trend in the forecast period.
The Norovirus Infection Diagnostics Market report by Persistence Market Research throws light on the fact that the healthcare industry is more towards value-based care and continuous improvements based on the feedback. The mainstreaming of this practice is increasing all through. As such, the healthcare providers could make way for customized, lasting, and effective solutions to render utmost care to patients.
Norovirus is a contagious disease that causes severe diarrhea and vomiting, a condition called as acute gastroenteritis. According to CDC, norovirus is the most common cause of acute gastroenteritis, affecting 685 million cases worldwide.
There is currently no vaccine or treatment option available for the cure of the gastro inflammation caused by the norovirus infection. This norovirus infection is highly contagious and can easily spread through virus contaminated food or water as well as by touching infected person. A very few virus particles, even in extreme conditions are capable of infecting and causing ‘stomach flu’.
How about looking through the sample of Norovirus Infection Diagnostics market report? https://www.persistencemarketresearch.com/samples/25924
Get A Customized Scope To Match Your Need Ask An Expert – email@example.com
Norovirus infection diagnostics consists of a series of tests performed in order to detect viral antigen or viral RNA. The Norovirus infection diagnostics not just require any standard set of diagnostic tool but it requires deep patient expertise and knowledge about the disease pathogen.
Most of the recent advances in norovirus infection diagnostics has implemented many new diagnostic tests such as RT-qPCR assays to detect the RNA of the norovirus, multiplex gastrointestinal platforms to detect multiple gastrointestinal pathogens and many more such tests. Also, rapid commercially available enzyme immunoassays (EIAs) are also available in the industry that aids detection of the norovirus antigen in test samples.
However, these enzyme immunoassays have poor sensitivity of 50 to 75%, and thus are not usually recommended as the preference for norovirus infection diagnostics. Patients are recommend to use RT-qPCR assays as the norovirus infection diagnostics method over others on the account of being highly sensitive and specific.
Technology has benefitted the diagnostic products with suited automation and control features to enhance the output required from a norovirus infection diagnostics needed for patient care. Doctors have recommend that using RT-qPCR norovirus infection diagnostics is more prominent for an effective early treatment with early detection of norovirus.
Want a sneak peek into the Norovirus Infection Diagnostics market? Access the “Table of Content” of Norovirus Infection Diagnostics market report! https://www.persistencemarketresearch.com/toc/25924
The growing adoption and availability of norovirus infection diagnostic techniques, particularly in major countries including United States, China, Germany and some countries of Asia-Pacific is projected to propel norovirus infection diagnostics market growth over the coming years. The norovirus infection diagnostics market is categorized on the basis of product type and end user. On the basis of product type, the norovirus infection diagnostics market is classified into four broad categories including microscopy, immunological tests, molecular tests, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Luminex assays.
Growing prevalence of norovirus infection and commercial availability of distinct norovirus infection diagnostics method is anticipated to be the primary factor fueling the growth of norovirus infection diagnostics market over the globe. Over 50% of all the foodborne disease outbreaks across the world are attributed to noroviruses, thus there is an increase in demand for norovirus infection diagnostics which further drive the revenue generation in norovirus infection diagnostics market.
Moreover, advancing technology and development of enhanced diagnostic tests that receive fast FDA clearance for norovirus testing are also responsible to drive the norovirus infection diagnostics market over forecast period. However, high costs of norovirus infection diagnostics and increase in product recalls is restraining the current norovirus infection diagnostics market growth.
The global Norovirus Infection Diagnostics market is segmented on basis of product type, end user and geographic region:
By Product Type
- Electron Microscopy
- Transmission Electron Microscopy
- Immunological Tests
- Immunochromatographic Testing
- Molecular Tests
- Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
- Luminex Assay
- By End User
- Diagnostic Laboratories
On the basis of product type, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) norovirus infection diagnostic test registered highest revenue generation and is further anticipated to dominate the norovirus infection diagnostics market over the forecast period on the account of being most precise method of norovirus detection. Whereas, among end users hospitals followed by diagnostic laboratories is anticipated to register highest growth rate over the forecast period.
Want to step into the unexplored territories of the Norovirus Infection Diagnostics market? Prebook our Norovirus Infection Diagnostics market report to look through the merits of your decision! https://www.persistencemarketresearch.com/checkout/25924
Based on geography, global norovirus infection diagnostics market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. U.S. in North America registered the largest revenue shares in global norovirus infection diagnostics market owing to the increased burden of norovirus illness in the U.S. North America is followed by Europe and Asia-Pacific.
In Europe, the norovirus infection diagnostics market is gaining importance due to increased awareness among people for early diagnosis of norovirus infection in order to get effective treatment. However, in Middle East and Africa region norovirus infection diagnostics are not used at a great extent due to lack of personnel expertise in diagnostic labs and hospitals.
Some of the key players involved in global norovirus infection diagnostics market are Luminex Corporation, Cepheid Inc. (Danaher Corporation), R-Biopharm AG, Abbott Laboratories, Inc., Microbac Laboratories, Inc., ELITech Group SAS, Certest Biotec S.L., NanoEnTek Inc., BioMérieux, Operon Biotechnologies, Inc. among others.
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com
Why pay for news and opinions when you can get them for free?
Subscribe for free now!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact